Key result
Continuous real-time monitoring combined with cardiac troponins may improve CVD risk assessment.
Why the study?
Does continuous real-time monitoring of systemic inflammation improve cardiovascular disease risk assessment compared to single-point-in-time blood tests in primary prevention?
Does continuous real-time monitoring of systemic inflammation improve cardiovascular disease risk assessment compared to single-point-in-time blood tests in primary prevention?
Continuous real-time monitoring of systemic inflammation using new technological devices may offer a more accurate approach to cardiovascular disease risk assessment than traditional single-point-in-time blood tests.
Answers are grounded in this paper and cite their sources.
May support continuous monitoring for dynamic CVD risk assessment; leaves open prospective validation versus single-point tests.
Purpose of review The prediction of cardiovascular disease (CVD) events is of strategic importance for the primary prevention of one of the big killers in the world. Predictive models have a history of decades, but still the desired accuracy is not reached by any of the existing models. The inclusion of inflammatory factors in the models did not increase their accuracy. In this review, we discuss the possible reasons for that failure and we propose a paradigm shift. Recent findings Systemic inflammation is a very volatile phenomenon. The blood concentration of inflammatory biomarkers may change considerably in one individual with a timescale of seconds. Sudden changes in environmental conditions can trigger rapid modifications in the inflammatory profile of an individual. In routine clinical practice, the blood tests for inflammation are carried out at one point in time, not in standard environmental conditions, and are therefore inadequate. Summary We have to direct CVD research toward the understanding of the synchronic relationship between external environmental conditions and internal physiological reactions. CVD risk assessment must be carried out by using continuous real-time monitoring of external and internal parameters together, something that may become possible with the advent of new technological devices.
No takes yet. Share an insight, caveat, or question.
Antonio Ivan Lazzarino (2017) conducted a review in Cardiovascular disease. Continuous real-time monitoring of external and internal parameters was evaluated. Continuous real-time monitoring of external and internal parameters, in conjunction with proximal precursors like cardiac troponins, is proposed to improve cardiovascular disease risk assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: